Gender Bias and Medication Shortages in Women's Healthcare

• Persistent shortages of transdermal Hormone Replacement Therapy (HRT) medications are forcing women to struggle to find essential treatments for menopause and gender-affirming care.
• Sudden discontinuation of these treatments leads to significant health complications and a decrease in quality of life.

Systemic Healthcare Disparities

• The article highlights a pattern of normalizing pain in female patients, often referred to as obstetric and gynecological violence.
• Contrast in medical treatment protocols:
  • Gynecological procedures like IUD insertions and hysteroscopies are frequently performed without anesthesia despite intense pain, and patients are often expected to return to work immediately.
  • Similar urological procedures for men, such as transurethral resections, are typically performed with anesthesia.
• Frequent dismissal of women’s health issues, such as undiagnosed endometriosis, where severe pain is mischaracterized as normal menstrual discomfort.

Societal Implications

• Medications for conditions primarily affecting men are reportedly more stable in supply compared to transdermal HRT.
• The normalization of women's pain and the lack of reliable pharmaceutical access force patients to endure preventable suffering, reflecting deep-seated gender biases in medical practice and pharmaceutical distribution.